ArticleCancer chemotherapy and pharmacology2026
Development of a simplified population pharmacokinetic-pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment.
Yoshinori Makino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.